Editor's note: Seeking Alpha is proud to welcome Dineshkumar Muniyandi as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
Eros International (NYSE:EROS) is a leading global company in the Indian film entertainment industry, which co-produces, acquires and distributes Indian language films in multiple formats worldwide. Founded in 1977 by Arjun Lulla, Eros built its reputation for making high-quality content for past 40 years. EROS generates its revenue through its multi-platform business model that comprises Theatrical, Television Syndication, and Digital channels. In this article, I will present my case of why EROS is an undervalued at the current price.
Strong Film businessEROS has long-standing relationships with leading Bollywood directors and actors, allowing them to produce high-quality content seamlessly. Indian media industry is a close-knit group (not unlike Indian family culture) where it is difficult for a newcomer to create movies with leading actors, compared to companies like EROS with deep relationships. Being in the industry for 40 years, EROS has helped in identifying and launching the careers of several stars which will in turn help EROS grow.
Best Undervalued Stocks For 2019: MediWound Ltd.(MDWD)
Advisors' Opinion:- [By Money Morning Staff Reports]
After looking at this week's penny stock gainers, we'll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…
Penny Stock Current Share Price (March 26) Last Week's Gain Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69% Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90% iFresh Inc. (Nasdaq: IFMK) $8.25 64.64% China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43% National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29% Document Security Systems Inc. (NYSE: DSS) $1.58 33.91% Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90% CareDx Inc. (Nasdaq: CDNA) $7.49 29.88% Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51% New York & Co. Inc. (NYSE: NWY) $3.37 26.35%Don't Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…
- [By Max Byerly]
Get a free copy of the Zacks research report on Mediwound (MDWD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Mediwound (NASDAQ: MDWD) and True Drinks (OTCMKTS:TRUU) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Mediwound (MDWD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Media coverage about Mediwound (NASDAQ:MDWD) has been trending somewhat positive on Saturday, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Mediwound earned a news impact score of 0.17 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 47.1925876006011 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Best Undervalued Stocks For 2019: MISONIX Inc.(MSON)
Advisors' Opinion:- [By Ethan Ryder]
MISONIX (NASDAQ:MSON) posted its earnings results on Monday. The medical equipment provider reported $0.23 earnings per share for the quarter, Bloomberg Earnings reports. The company had revenue of $12.44 million during the quarter. MISONIX had a negative net margin of 28.12% and a negative return on equity of 11.13%.
- [By Ethan Ryder]
H2O Innovation (OTCMKTS:HEOFF) and Misonix (NASDAQ:MSON) are both small-cap industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership.
- [By Joseph Griffin]
Misonix (NASDAQ:MSON) and H2O Innovation (OTCMKTS:HEOFF) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.
- [By Stephan Byrd]
Cesca Therapeutics (NASDAQ: MSON) and Misonix (NASDAQ:MSON) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.
Best Undervalued Stocks For 2019: BlackRock Science and Technology Trust(BST)
Advisors' Opinion:- [By Shane Hupp]
Stifel Financial Corp increased its position in shares of BlackRock Science & Technology Trust (NYSE:BST) by 8.4% during the 1st quarter, Holdings Channel reports. The fund owned 108,307 shares of the company’s stock after acquiring an additional 8,402 shares during the quarter. Stifel Financial Corp’s holdings in BlackRock Science & Technology Trust were worth $3,256,000 at the end of the most recent quarter.
- [By Logan Wallace]
BlackRock Science & Technology Trust (NYSE:BST) announced a monthly dividend on Monday, February 4th, Wall Street Journal reports. Stockholders of record on Friday, February 15th will be given a dividend of 0.15 per share on Thursday, February 28th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 5.67%. The ex-dividend date is Thursday, February 14th.
No comments:
Post a Comment